Why India Is Becoming the Global Healthcare Destination in 2026
TL;DR: India's Union Budget 2026 committed Rs 1,06,530 crore (USD 12.7 billion) to healthcare — a 10% year-on-year increase — including five new regional medical tourism hubs. India treated 700,000+ international patients in 2025 and is projected to reach 1 million by 2027. Cost advantage vs. the USA: 60–80% across cardiac, oncology, and transplant procedures. (Source: Union Budget 2026, KPMG analysis)
India has long been on the radar of international patients seeking affordable, high-quality medical care. In 2026, that story has taken a decisive new turn. The Union Budget has committed Rs 1,06,530 crore to healthcare — a 10% increase year-on-year — and announced a sweeping set of reforms designed to establish India as a global healthcare hub. Five integrated regional medical tourism hubs, a Rs 10,000-crore biopharmaceutical programme, duty cuts on life-saving cancer drugs, and the fastest-growing medical tourist arrival numbers in Asia: the evidence is mounting.
This article explains what is driving the shift, what Budget 2026 means for international patients, and why India stands apart from competing destinations like Thailand, Singapore, and Turkey.
India's Union Budget 2026: A Healthcare Turning Point
India's Finance Minister presented the Union Budget 2026 with an explicit ambition to position the country as a global healthcare destination. The headline numbers are significant, but the structural commitments beneath them are what matter most for international patients.
According to analysis by KPMG, the budget signals a long-term policy intent — not just a one-year spending increase — to build the infrastructure, workforce, and regulatory ecosystem that can serve patients from every part of the world. You can read the full KPMG analysis here: Budget 2026 Aims to Position India as Global Healthcare Hub.
Key Budget Allocations for Health
| Allocation | Amount | Change |
|---|---|---|
| Total Health Budget | Rs 1,06,530 crore | +10% YoY |
| Dept. of Health & Family Welfare | Rs 1,01,709 crore | +9% |
| Dept. of Health Research | Rs 4,821 crore | +23% |
| National Health Mission | Rs 39,390 crore | +6% |
| AB-PMJAY (insurance scheme) | Rs 9,500 crore | +6% |
| ICMR (medical research) | Rs 4,000 crore | +27% |
| Mental Health Programme | Rs 51 crore | +14% |
| ABDM (digital health) | Rs 350 crore | +8% |
The 27% jump in ICMR funding and the 23% increase in health research spending reflect India's intent to move up the value chain — from a low-cost treatment destination to a research, innovation, and clinical trials hub.
Biopharma SHAKTI: Building World-Class Research Infrastructure
One of the most significant announcements for the healthcare sector is the Biopharma SHAKTI programme — a Rs 10,000-crore, five-year initiative that includes:
- Three new NIPERs (National Institutes of Pharmaceutical Education and Research) plus upgrades to seven existing institutions
- A network of 1,000+ accredited clinical trial sites across India
- Enhanced capabilities in biologics, biosimilars, and advanced therapy medicinal products
For international patients, this matters because it signals that India's hospitals and medical institutions are investing in cutting-edge capabilities — not just maintaining existing ones. Clinical trial infrastructure in particular attracts the world's best medical talent and the latest treatment protocols.
Five Regional Medical Tourism Hubs
The budget announces five integrated regional medical hubs across India. These are purpose-built facilities designed to serve international patients, with seamless coordination of hospital care, accommodation, visa facilitation, and interpreter services.
Medical tourist arrivals to India have grown from 1.12 lakh in 2009 to over 6 lakh in 2024 — a compound annual growth rate of approximately 12.4%. The five new hubs are designed to scale this number significantly by reducing friction for international patients: from the moment they decide to travel to the day they return home.
Workforce and Allied Health Professionals
Quality care depends on people as much as buildings. Budget 2026 commits to:
- Training 1.5 lakh caregivers through NSQF-aligned programmes
- Adding 1 lakh Allied Health Professionals across 10 disciplines, backed by a Rs 1,000 crore outlay
- Expanding emergency and trauma care capacity by 50% in district hospitals
This investment in frontline healthcare workers directly improves the patient experience for international visitors — from post-operative nursing to rehabilitation support.
Cancer Drug Duty Cuts: What It Means for Patients
The budget removes Basic Customs Duty on 17 life-saving cancer drugs and extends duty exemptions for seven rare disease medications. While the direct financial benefit flows to Indian consumers and healthcare providers, the downstream effect for international patients is meaningful: lower procurement costs for hospitals translate into more competitive treatment packages for oncology patients travelling from abroad.
India is already one of the world's most sought-after destinations for cancer treatment, offering therapies like CAR-T cell therapy, proton therapy, and robotic oncological surgery at a fraction of Western prices. These duty cuts strengthen that position further.
India's Medical Tourism Growth: The Numbers
The trajectory of India's medical tourism growth tells its own story:
- 2009: 1.12 lakh international medical tourists
- 2024: 6+ lakh international medical tourists
- CAGR: ~12.4% over 15 years
- Cost advantage: 60–80% lower than USA or UK for equivalent procedures
- JCI-accredited hospitals: 40+
- NABH-certified institutions: 700+
International patients come from over 100 countries. The largest source markets include Bangladesh, Afghanistan, Iraq, the Maldives, the UAE, Nigeria, Kenya, Tanzania, and Ethiopia. The combination of English-language care, visa accessibility, and established diaspora communities makes the patient journey less daunting than it might be in Thailand or Singapore.
What Makes India Different from Thailand and Singapore
India competes primarily with Thailand, Singapore, and Turkey for international medical patients. Here is how it differs in 2026:
Cost
India remains the most cost-competitive major medical tourism destination globally. A knee replacement that costs $50,000 in the USA costs $8,000–$12,000 in Singapore, $7,000–$10,000 in Thailand, and $4,000–$7,000 in India — with comparable quality at India's top hospitals.
Speciality Depth
India has more sub-speciality expertise than any other emerging medical tourism destination. For complex procedures — multi-organ transplants, paediatric cardiac surgery, bone marrow transplantation, robotic oncology surgery — India's top hospitals offer a depth of experience that few countries outside the USA and Germany can match.
English-Language Care
India's medical system is built on English. Medical records, consultations, discharge summaries, and post-operative instructions are all in English — removing a significant barrier for patients from Africa, the Middle East, and South Asia.
Policy Momentum
Budget 2026 represents a structural, government-backed commitment to medical tourism — not just market forces. No other country in the region has announced a comparable combination of dedicated tourism hubs, research investment, and drug policy reforms in a single budget cycle.
Top Specialties for International Patients in India
India's hospitals have built global reputations across a range of specialties:
Cardiac Surgery and Cardiology
India performs more cardiac surgeries per year than any country outside the USA. Hospitals like Narayana Health in Bengaluru, Fortis Escorts in Delhi, and Apollo in Chennai deliver bypass surgery success rates of 95–98% at costs of $4,500–$12,000 — compared to $70,000–$150,000 in the USA.
Oncology and Cancer Care
Comprehensive cancer centres across Delhi, Mumbai, and Chennai offer medical oncology, radiation oncology, surgical oncology, and the latest targeted therapies. Duty cuts on 17 cancer drugs in Budget 2026 reduce the cost of biologic and immunotherapy treatments.
Organ Transplantation
India is one of the few countries in the world where living-donor kidney, liver, and heart transplants are performed at high volume. Outcomes at leading centres are comparable to those published by the best Western programmes.
Orthopaedics and Joint Replacement
Joint replacement packages in India — including bilateral knee or hip replacement — typically cost $5,000–$9,000 for the surgery and full hospitalisation, compared to $40,000–$50,000 in the USA.
IVF and Fertility
India is a global leader in IVF, egg donation, and surrogacy (where legally permitted). Fertility clinics in Delhi, Mumbai, and Bengaluru are internationally accredited and treat thousands of international couples annually.
Neurosurgery and Spine Surgery
Complex spine procedures, deep brain stimulation, and neurovascular surgeries are performed at high volumes in India's tertiary care centres, with costs significantly below those in Western countries.
Accreditation and Quality Standards
Quality and safety are non-negotiable for international patients. India's top hospitals hold some of the most rigorous international accreditations:
- JCI (Joint Commission International): Over 40 Indian hospitals — the same body that accredits leading US hospitals
- NABH (National Accreditation Board for Hospitals): Over 700 institutions certified under India's national standard
- ISO 9001 / ISO 15189: Common across diagnostic and laboratory facilities
When choosing a hospital in India, look for JCI or NABH certification as a baseline. Major hospital groups — Apollo, Fortis, Medanta, Max, Narayana, and Kokilaben — all hold multiple accreditations and publish their outcome data publicly.
The Role of Technology: AI, Robotics, and Telemedicine
India's healthcare sector is not just cost-competitive — it is technologically progressive. In 2026:
- Robotic surgery (da Vinci, Versius, and homegrown systems) is available at over 50 hospitals across India for urology, gynaecology, cardiac, and oncology procedures
- AI-assisted diagnostics are deployed at scale in radiology and pathology at leading institutions
- Telemedicine allows international patients to consult specialists before travelling, reducing uncertainty and enabling faster pre-operative planning
- ABDM (Ayushman Bharat Digital Mission) — funded at Rs 350 crore in Budget 2026 — is building a national digital health backbone that enables seamless transfer of medical records across institutions
For international patients, telemedicine consultations before travel are now standard practice at all major hospitals. Most hospitals offer dedicated international patient departments with multilingual coordinators who manage the full patient journey from enquiry to follow-up.
How to Plan Your Medical Trip to India in 2026
If you are considering travelling to India for medical treatment, here is a practical framework:
1. Define Your Treatment Need
Start with a clear diagnosis and a second opinion from a specialist in your home country. Bring all original reports, imaging (MRI, CT, PET scans), and blood work.
2. Choose Accredited Hospitals
Research JCI or NABH-accredited hospitals with demonstrated experience in your specific procedure. Compare outcome data, surgeon credentials, and patient testimonials.
3. Request a Treatment Plan and Cost Estimate
Most major hospitals provide free online consultations for international patients. Ask for a full cost breakdown — including surgeon fees, hospital stay, diagnostics, medications, and follow-up consultations.
4. Apply for a Medical Visa (M-Visa)
The Indian M-Visa is required for medical treatment visits. It is valid for up to 60 days with triple entry. Up to two companions can apply for a Medical Attendant Visa (MX-Visa). You will need a hospital appointment letter and proof of funds.
5. Plan Accommodation and Recovery
Many hospitals offer on-campus patient accommodation or have partnerships with nearby hotels. Budget for at least two to four weeks in India, depending on your procedure.
6. Arrange Travel Insurance
Choose a policy that covers medical treatment abroad, emergency evacuation, and potential stay extensions due to recovery complications.
Conclusion
India in 2026 is not simply a cheaper alternative to Western healthcare — it is an increasingly sophisticated, policy-backed, and internationally accredited medical ecosystem. The Union Budget 2026 has put significant state resources behind the ambition to make India the world's foremost medical tourism destination: five regional hubs, a Rs 10,000-crore research programme, duty cuts on cancer drugs, and the largest allied health workforce expansion in a decade.
For international patients, the practical implication is clear: India offers a combination of cost savings, speciality depth, English-language care, and quality assurance that no other country in the region can match at scale.
If you are considering treatment in India, speak with the Arodya team — we help international patients navigate hospital selection, visa applications, travel logistics, and cost planning at no charge.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Statistics and budget figures are sourced from official Indian government announcements and publicly available analysis, including KPMG's Budget 2026 healthcare commentary. Always consult qualified healthcare professionals for medical decisions.
